JNJ-64991524

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-64991524, covering 2019-01-24 to 2019-01-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-64991524 in Healthy Participants [Phase 1]

See pricing